Concepedia

Lilach Steiner

LS

Statistics

Publications

6

Citations

479

H-Index

6

Active since

2007

Affiliations

Teva Pharmaceuticals (Israel)(Current)

Hebrew University of Jerusalem

Queen's University Belfast

University of Ulster

Lilach Steiner is an author at Teva Pharmaceuticals (Israel) specializing in pharmacology, medicine, and parkinson’s disease pharmacotherapy.

Publications per year

2007–2020

6

Publications

6

Hydrogel-forming microneedle arrays as a therapeutic option for transdermal esketamine delivery

Aaron J. Courtenay, Emma McAlister, Maelíosa McCrudden et al. · Journal of Controlled Release · 2020 · 155 citations · Full text

, , +11

Therapeutic Destruction of Insulin Receptor Substrates for Cancer Treatment

Hadas Reuveni, Efrat Flashner-Abramson, Lilach Steiner et al. · Cancer Research · 2013 · 123 citations · Full text

, , +15

Directly Compressed Tablets: A Novel Drug‐Containing Reservoir Combined with Hydrogel‐Forming Microneedle Arrays for Transdermal Drug Delivery

Emma McAlister, Bridie Dutton, Lalitkumar K. Vora et al. · Advanced Healthcare Materials · 2020 · 84 citations · Full text

, , +17

Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson's Disease

Veronica Francardo, Michal Geva, Francesco Bez et al. · Neurotherapeutics · 2019 · 63 citations · Full text

, , +17

Pridopidine, a clinic‐ready compound, reduces 3,4‐dihydroxyphenylalanine‐induced dyskinesia in Parkinsonian macaques

Tom H. Johnston, Michal Geva, Lilach Steiner et al. · Movement Disorders · 2018 · 37 citations

, , +17

1–5 of 6